Browse By Publication: Clinical Lung Cancer
|Up a level|
Number of items: 5.
Gately, K., Collins, I., Forde, L., Al-Alao, B., Young, V., Gerg, M., et al. (2011) A role for IGF-1R-targeted therapies in small-cell lung cancer? Clinical Lung Cancer, 12(1), pp. 38-42.
Gately, Kathy, Forde, Lydia, Cuffe, Sinead, Cummins, Robert, Kay, Elaine, Feuerhake, Friedrich, et al. (2014) High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer. Clinical Lung Cancer, 15(1), pp. 58-66.
Gray, Steven G., Al-Sarraf, Nael, Baird, Anne-Marie, Gately, Kathy, McGovern, Eilish, & O'Byrne, Kenneth J. (2008) Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells. Clinical Lung Cancer, 9(6), pp. 367-374.
Spigel, David R., Edelman, Martin J., Mok, Tony, O'Byrne, Kenneth J., Paz-Ares, Luis, Yu, Wei, et al. (2012) Treatment rationale study design for the MetLung trial : a randomized, double-blind phase III study of onartuzumab (MetMAb) in combination with erlotinib versus erlotinib alone in patients who have received standard chemotherapy for stage IIIB or IV met-positive non-small-cell lung cancer. Clinical Lung Cancer, 13(6), pp. 500-504.
Swinson, Daniel E. B. & O'Byrne, Kenneth J. (2006) Interactions between hypoxia and epidermal growth factor receptor in non-small-cell-lung cancer. Clinical Lung Cancer, 7(4), pp. 250-256.